Strong Operational Performance in FY 2025–26 - Hindustan Copper Ltd

Code BSE: 513599 NSE:

Granules India Limited today announced that its wholly-owned subsidiary, Granules Pharmaceuticals, Inc. (GPI), located in Chantilly, Virginia, US, has completed a routine current Good Manufacturing Practices (cGMP) audit by the US Food and Drug Administration with four Form 483 observations. Granules remains committed to maintaining the highest standards of quality, safety, and regulatory compliance and will address the observations raised by the US FDA within the stipulated timelines.